HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marco Donatello Delcuratolo Selected Research

Marco Donatello Delcuratolo Research Topics

Disease

5Neoplasms (Cancer)
01/2023 - 01/2020
3Lung Neoplasms (Lung Cancer)
03/2024 - 01/2021
2Carcinoma (Carcinomatosis)
11/2022 - 01/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2024
1Renal Cell Carcinoma (Grawitz Tumor)
01/2023
1Non-Muscle Invasive Bladder Neoplasms
01/2022
1Prostatic Neoplasms (Prostate Cancer)
01/2022
1Disease Progression
01/2020
1Thymoma (Thymic Carcinoma)
01/2020
1Aplastic Anemia (Anemia, Hypoplastic)
01/2020

Drug/Important Bio-Agent (IBA)

3Immune Checkpoint InhibitorsIBA
01/2022 - 01/2021
2pembrolizumabIBA
03/2024 - 01/2022
1PlatinumIBA
03/2024
1Pemetrexed (MTA)FDA Link
03/2024
1Carboplatin (JM8)FDA LinkGeneric
03/2024
1BNT162 VaccineIBA
01/2023
1COVID-19 VaccinesIBA
01/2023
1Messenger RNA (mRNA)IBA
01/2023
1Biological FactorsIBA
01/2023
1AminesIBA
11/2022
1Benzene (Benzole)IBA
11/2022
1SmokeIBA
11/2022
1erdafitinibIBA
01/2022
1enfortumab vedotinIBA
01/2022
1NectinsIBA
01/2022
1AndrogensIBA
01/2022
1Immunoconjugates (Immunoconjugate)IBA
01/2022
1Biomarkers (Surrogate Marker)IBA
09/2021
1durvalumabIBA
01/2021
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2020

Therapy/Procedure

4Immunotherapy
03/2024 - 12/2021
3Therapeutics
01/2022 - 01/2020
1Precision Medicine
11/2022
1Molecular Targeted Therapy
09/2021
1Drug Therapy (Chemotherapy)
01/2020